Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

Stephen Dorrell

MPs pharma investigation in offing

November 26, 2012
Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data

A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …

News
NICE image

NICE medicines uptake dissected

November 23, 2012
Sales and Marketing HSCIC, IMS, NICE

Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …

News
Alex Neil

SMC put under review

November 20, 2012
Sales and Marketing Alex Neil, NICE, SMC, Scotland

The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …

News

Patients ‘shut out’ of drug price talks

November 13, 2012
Sales and Marketing Cancer, NHS, NICE, VBP, prostate

Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …

News
yervoy image

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012
Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

News
ABPI image

ABPI slams NHS findings

October 18, 2012
Sales and Marketing ABPI, Lucentis, NICE, UK

The ABPI has expressed concern at a report by the NHS’s Health and Social Care Information Centre (HSCIC) which suggests …

News
NICE image

NICE publishes first off-label summary

October 18, 2012
Sales and Marketing NICE, UK, prescribing

In a radical change to its modus operandi, NICE has published the first in an ongoing series of assessments of …

News
Avastin image

Scotland ‘no’ to Avastin

October 9, 2012
Sales and Marketing NICE, Roche, Scotland, avastin

Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …

News
Lucentis image

NICE does Lucentis U-turn

October 5, 2012
Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin

NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …

News

Innovation scorecard gets ABPI thumbs-up

August 29, 2012
Sales and Marketing NHS, NICE, market access

 An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …

News
NHS image

UK government pushes through formulary changes

August 22, 2012
Sales and Marketing CCGs, NHS, NICE, PCTs, UK, lottery, prescribing

The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …

News
Avastin image

Another NICE no for Avastin in breast cancer

August 22, 2012
Sales and Marketing NICE, avastin, breast cancer, rejection

Roche’s Avastin has been rejected once again for use in breast cancer patients.  NICE has now issued final guidance saying …

News
Whitehead image

NICE bows to industry pressure

August 21, 2012
Sales and Marketing ABPI, NICE, QALY, VBP

NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …

News
ABPI image

ABPI slams NICE International

August 20, 2012
Sales and Marketing ABPI, NICE, NICE International, Romania, hta

The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

News
Xgeva image

Xgeva gains NICE recommendation for bone metastasis

August 17, 2012
Sales and Marketing Amgen, NICE, Xgeva, bone metastatis

NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026